It has been suggested that the pharmacological inhibition of SRC signaling could be beneficial in the treatment of advanced thyroid cancer, as it was shown to reduce tumor cell growth and metastasis, both in vitro and in vivo [83,84,85]. The gene discussed is SRC; the disease is thyroid gland carcinoma.